Ultra High-risk Gestational Trophoblastic Neoplasia

IF 2.5 3区医学 Q2 HEMATOLOGY Hematology-Oncology Clinics of North America Pub Date : 2024-09-27 DOI:10.1016/j.hoc.2024.08.015

Kevin M. Elias MD , Ross S. Berkowitz MD , Neil S. Horowitz MD

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

超高危妊娠滋养细胞肿瘤。

超高危妊娠滋养细胞肿瘤（GTN）是指世界卫生组织预后风险评分至少为 13 分的患者。这些患者的平均死亡风险为 30%。超高危妊娠母细胞瘤多表现为肿瘤体积增大、肝脏和/或脑部转移以及人类绒毛膜促性腺激素水平非常高。诊断评估必须包括对中枢神经系统疾病的全面评估。及时启动顺铂-依托泊苷诱导化疗可降低早期死亡的风险。可能需要神经外科、肿瘤放射科和介入放射科等协作服务来处理出血性病变。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Hematology-Oncology Clinics of North America 医学-血液学

CiteScore

4.10

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： Hematology/Oncology Clinics updates you on the latest trends in patient management, keeps you up to date on the newest advances, and provides a sound basis for choosing treatment options. Under the direction of an experienced guest editor, each issue focuses on a single topic in hematology and oncology, including hemostasis and thrombosis, molecular and cellular basis of hematology, coagulation disorders, and cancers—bone, gastrointestinal, head and neck, lymphomas, neuroendocrine, breast, renal cell, melanoma, and more.

期刊最新文献

Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond. Gene Signatures and Oncology Treatment Implications. Heavy Ion Particle Therapy in Modern Day Radiation Oncology. Patient-Reported Outcomes in Radiation Oncology. Contents